Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

BACKGROUND: Patients with heart failure with preserved ejection fraction have significant impairment in health-related quality of life. In the EMPEROR-Preserved trial (Empagliflozin Outcome Trial in Patients With Chronic Heart Failure With Preserved Ejection Fraction), we evaluated the efficacy of e...

Descripción completa

Detalles Bibliográficos
Autores principales: Butler, Javed, Filippatos, Gerasimos, Jamal Siddiqi, Tariq, Brueckmann, Martina, Böhm, Michael, Chopra, Vijay K., Pedro Ferreira, João, Januzzi, James L., Kaul, Sanjay, Piña, Ileana L., Ponikowski, Piotr, Shah, Sanjiv J., Senni, Michele, Vedin, Ola, Verma, Subodh, Peil, Barbara, Pocock, Stuart J., Zannad, Faiez, Packer, Milton, Anker, Stefan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763045/
https://www.ncbi.nlm.nih.gov/pubmed/34779658
http://dx.doi.org/10.1161/CIRCULATIONAHA.121.057812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763045/
https://www.ncbi.nlm.nih.gov/pubmed/34779658
http://dx.doi.org/10.1161/CIRCULATIONAHA.121.057812

Ejemplares similares